Clinical efficacy of Gamma Knife® combined with transarterial chemoembolization and immunotherapy in the treatment of primary liver cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-4)

Sum=56

Jun 27, 2024 (publication date) through Jun 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Jun 27, 2024; 16(6): 1601-1608
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1601

Table 2 Clinical efficacy evaluation of 51 patients with primary liver cancer, n (%)

CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease.

Citation: Wang GF, Shu CX, Cai XD, Wang HB, Xu JH, Jia YQ. Clinical efficacy of Gamma Knife^® combined with transarterial chemoembolization and immunotherapy in the treatment of primary liver cancer. World J Gastrointest Surg 2024; 16(6): 1601-1608
URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1601.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1601